Pages that link to "Q35119997"
Jump to navigation
Jump to search
The following pages link to Thresholds for the cost-effectiveness of interventions: alternative approaches (Q35119997):
Displaying 50 items.
- Screening for Tuberculosis Among Adults Newly Diagnosed With HIV in Sub-Saharan Africa: A Cost-Effectiveness Analysis (Q26779464) (← links)
- Dynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low- and Middle-Income Countries: A Systematic Literature Review (Q28072167) (← links)
- Using Economic Evidence to Set Healthcare Priorities in Low-Income and Lower-Middle-Income Countries: A Systematic Review of Methodological Frameworks (Q28074172) (← links)
- A review of typhoid fever transmission dynamic models and economic evaluations of vaccination (Q28088491) (← links)
- Economic Evaluation of Family Planning Interventions in Low and Middle Income Countries; A Systematic Review (Q28354063) (← links)
- Improving Maternal Care through a State-Wide Health Insurance Program: A Cost and Cost-Effectiveness Study in Rural Nigeria. (Q30062123) (← links)
- What Pertussis Mortality Rates Make Maternal Acellular Pertussis Immunization Cost-Effective in Low- and Middle-Income Countries? A Decision Analysis. (Q30380534) (← links)
- Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy, Intensity-modulated Radiotherapy, and Proton Beam Therapy (Q30400574) (← links)
- How much might a society spend on life-saving interventions at different ages while remaining cost-effective? A case study in a country with detailed data (Q30979258) (← links)
- Investment Success in Public Health: An Analysis of the Cost-Effectiveness and Cost-Benefit of the Global Programme to Eliminate Lymphatic Filariasis (Q33603042) (← links)
- Cost-effectiveness analysis of malaria rapid diagnostic tests for appropriate treatment of malaria at the community level in Uganda (Q33608173) (← links)
- Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study (Q33692293) (← links)
- Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings (Q33773373) (← links)
- Cost-effectiveness analysis of malaria interventions using disability adjusted life years: a systematic review. (Q33862627) (← links)
- Impact and cost-effectiveness of rotavirus vaccination in Bangladesh (Q33907724) (← links)
- The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa. (Q35881727) (← links)
- Cost-Effectiveness of Automated Digital Microscopy for Diagnosis of Active Tuberculosis (Q36056621) (← links)
- Costs and Cost-Effectiveness of Hypertension Screening and Treatment in Adults with Hypertension in Rural Nigeria in the Context of a Health Insurance Program (Q36062367) (← links)
- Cost-Effectiveness of Surveillance for Bloodstream Infections for Sepsis Management in Low-Resource Settings (Q36132066) (← links)
- Cost-effectiveness of a national population-based screening program for type 2 diabetes: the Brazil experience (Q36235072) (← links)
- Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced Melanoma (Q36286084) (← links)
- Global economic evaluations of rotavirus vaccines: A systematic review (Q36371703) (← links)
- Cost-effectiveness and cost-utility analysis of OTC use of simvastatin 10 mg for the primary prevention of myocardial infarction in Iranian men. (Q36419621) (← links)
- Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: investment needs, population health gains, and cost-effectiveness (Q37244536) (← links)
- Proceedings of the Fourth Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies (Q37428776) (← links)
- Prioritizing health system and disease burden factors: an evaluation of the net benefit of transferring health technology interventions to different districts in Zimbabwe (Q37446922) (← links)
- Cost-effectiveness thresholds: pros and cons (Q37498173) (← links)
- How to Get Cost-Effectiveness Analysis Right? The Case of Vaccine Economics in Latin America (Q37540362) (← links)
- Cost effectiveness of a government supported policy strategy to decrease sodium intake: global analysis across 183 nations (Q37578449) (← links)
- Home-based versus center-based care in children with cerebral palsy: a cost-effectiveness analysis (Q37655686) (← links)
- Cost-effectiveness analysis of a universal mass vaccination program with a PHiD-CV 2 1 schedule in Malaysia (Q38602904) (← links)
- Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis (Q38631865) (← links)
- Evidence on the cost-effectiveness of lifelong antiretroviral therapy for prevention of mother-to-child transmission of HIV: implications for resource-limited countries in sub-Saharan Africa (Q38647745) (← links)
- A systematic review of the health economic consequences of quadrivalent influenza vaccination. (Q38671179) (← links)
- Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study (Q38671667) (← links)
- Cost-effectiveness analysis of anidulafungin vs fluconazole for the treatment of invasive candidiasis (IC) in Turkey (Q38682970) (← links)
- Rapid evidence review of the comparative effectiveness, harms, and cost-effectiveness of pharmacogenomics-guided antidepressant treatment versus usual care for major depressive disorder (Q38812608) (← links)
- Sustainable Financing of Innovative Therapies: A Review of Approaches (Q38850678) (← links)
- Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting (Q38850707) (← links)
- Echocardiographic Screening for Rheumatic Heart Disease in Indigenous Australian Children: A Cost-Utility Analysis. (Q38932245) (← links)
- Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review. (Q38940016) (← links)
- Cost-effectiveness of interventions to prevent road traffic injuries in low- and middle-income countries: A literature review (Q38941183) (← links)
- Next-generation multiple myeloma treatment: a pharmacoeconomic perspective (Q38981247) (← links)
- A systematic review of health economic evaluations of vaccines in Brazil. (Q38995392) (← links)
- Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer (Q39015252) (← links)
- Bubble continuous positive airway pressure in the treatment of severe paediatric pneumonia in Malawi: a cost-effectiveness analysis (Q39145737) (← links)
- Cost-Effectiveness of Histamine2 Receptor Antagonists Versus Proton Pump Inhibitors for Stress Ulcer Prophylaxis in Critically Ill Patients (Q39220800) (← links)
- Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models (Q39245552) (← links)
- Provision of hearing aids to children in Bangladesh: costs and cost-effectiveness of a community-based and a centre-based approach. (Q39515320) (← links)
- Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis (Q39574817) (← links)